细胞外囊泡,循环瘤细胞和免疫检查点抑制剂:暗示和承诺
Sara Bandini1, Paola Ulivi1, Tania Rossi1
1Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
Cells
|February 23, 2024
概括
细胞外囊泡 (EVs) 和循环瘤细胞 (CTCs) 显示为免疫检查点抑制剂 (ICI) 治疗的生物标志物具有前景. 对EV和CTC的研究可以推进个性化癌症免疫疗法,并预测治疗反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 免疫检查点抑制剂 (ICI) 疗法改变了癌症治疗,尤其是肺癌.
- 液体活检通过识别预测生物标志物提供了个性化治疗的潜力.
- 细胞外囊泡 (EV) 和循环瘤细胞 (CTC) 是液体活检的关键组成部分.
研究的目的:
- 审查使用EV和CTC识别免疫检查点的最新进展.
- 讨论EV和CTC作为ICI治疗预测生物标志物的潜力.
- 探索EV和CTC作为免疫治疗中创新的临床工具的未来使用.
主要方法:
- 电动汽车和CTC的分子特征.
- 对EV和CTC的表面抗原和货物含量的分析.
- 对EV,CTC和ICI治疗的当前文献的综述.
主要成果:
- EV和CTC可以调节瘤微环境和免疫反应.
- 在EV和CTC上的表面抗原可以表明免疫逃生机制.
- 可以设计EV和CTC来增强对组合疗法的免疫反应.
结论:
- EV和CTC作为ICI治疗有效性的预测生物标志物具有显著的潜力.
- 对EV和CTC进行进一步的研究是有必要的,以优化其在精密免疫治疗中的临床应用.
- 美国食品和药物管理局批准了CTC,强调了这些生物标志物的临床相关性.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
699
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
